Home Tags Alzheimer’s
Bill Gates says there could be a way to predict Alzheimer’s using a voice app that listens for ‘warning signs’
Gates envisions a future where people predict Alzheimer's before symptoms appear using the sound of our voices.
Your multivitamins and brain-boosting pills may be suspect, and regulators are cracking down on the $40 billion industry
Federal regulators announced this week that they'll be taking a more active role in policing the $40 billion supplement industry.
The 96-year-old who won the 2018 Nobel Prize in physics reveals his science-backed secret to staying sharp in old age
Arthur Ashkin is the oldest person ever awarded a Nobel Prize. But he says he's not done discovering yet. He still works every day.
Drug giant Pfizer isn’t ready to abandon neuroscience — here’s its $150-million ‘star cluster’ strategy for betting on p...
Execs from pharma giant Pfizer shared their strategy for keeping an eye on neuroscience — if not from the front row, then at least from the sidelines.
If you're looking to eat healthier, lose weight, and have more energy during the day, researchers advise trying a plant-based or Mediterranean diet.
There are about 50 million people in the world living with dementia. Here's what it's like for the people taking care of them.
There are about 50 million people living with dementia in the world, but there are still many misconceptions about what causes the symptoms. Here are some of the surprising facts about the diseases that cause dementia, and how they affect someone.
We just got more information on the first positive Alzheimer’s trial in years — here’s what you need to know
In July, drugmakers Biogen and Eisai announced positive results to its experimental Alzheimer's drug, known as BAN2401. It was the first time in years that the pharmaceutical industry has had a positive Alzheimer's trial, and the news sent Biogen skyrocketing.
A company that’s taking a new approach to tackling Alzheimer’s is moving into human trials after raising $133 million
Biotech startup Alector is getting ready to put its first batch of neurodegenerative drugs into humans after raising an additional $133 million. Alector is developing treatments that harness the body's immune system to tackle conditions like Alzheimer's, and other forms of dementia.
Meet the 29-year-old who founded a company that’s using technology to find treatments for diseases thought to be incurable
Verge Genomics is using technology to develop new treatments for diseases thought to be incurable such as Alzheimer's, Parkinson's and ALS.